CCCC
Price
$1.48
Change
-$0.04 (-2.63%)
Updated
Jul 3 closing price
Capitalization
105.09M
31 days until earnings call
INTS
Price
$0.30
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
7.69M
43 days until earnings call
Interact to see
Advertisement

CCCC vs INTS

Header iconCCCC vs INTS Comparison
Open Charts CCCC vs INTSBanner chart's image
C4 Therapeutics
Price$1.48
Change-$0.04 (-2.63%)
Volume$728.17K
Capitalization105.09M
Intensity Therapeutics
Price$0.30
Change-$0.00 (-0.00%)
Volume$1.23M
Capitalization7.69M
CCCC vs INTS Comparison Chart in %
Loading...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CCCC vs. INTS commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCCC is a Hold and INTS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (CCCC: $1.48 vs. INTS: $0.30)
Brand notoriety: CCCC and INTS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CCCC: 66% vs. INTS: 75%
Market capitalization -- CCCC: $105.09M vs. INTS: $7.69M
CCCC [@Biotechnology] is valued at $105.09M. INTS’s [@Biotechnology] market capitalization is $7.69M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CCCC’s FA Score shows that 1 FA rating(s) are green whileINTS’s FA Score has 0 green FA rating(s).

  • CCCC’s FA Score: 1 green, 4 red.
  • INTS’s FA Score: 0 green, 5 red.
According to our system of comparison, CCCC is a better buy in the long-term than INTS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CCCC’s TA Score shows that 3 TA indicator(s) are bullish while INTS’s TA Score has 3 bullish TA indicator(s).

  • CCCC’s TA Score: 3 bullish, 6 bearish.
  • INTS’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, INTS is a better buy in the short-term than CCCC.

Price Growth

CCCC (@Biotechnology) experienced а -2.63% price change this week, while INTS (@Biotechnology) price change was -3.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

CCCC is expected to report earnings on Oct 30, 2025.

INTS is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CCCC($105M) has a higher market cap than INTS($7.7M). CCCC YTD gains are higher at: -58.889 vs. INTS (-83.233). INTS has higher annual earnings (EBITDA): -14.92M vs. CCCC (-102.74M). CCCC has more cash in the bank: 215M vs. INTS (929K). INTS has less debt than CCCC: INTS (131K) vs CCCC (64.4M). CCCC has higher revenues than INTS: CCCC (39.8M) vs INTS (0).
CCCCINTSCCCC / INTS
Capitalization105M7.7M1,365%
EBITDA-102.74M-14.92M689%
Gain YTD-58.889-83.23371%
P/E RatioN/AN/A-
Revenue39.8M0-
Total Cash215M929K23,143%
Total Debt64.4M131K49,160%
TECHNICAL ANALYSIS
Technical Analysis
CCCCINTS
RSI
ODDS (%)
N/A
Bullish Trend 5 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
63%
Momentum
ODDS (%)
Bullish Trend 4 days ago
82%
Bearish Trend 4 days ago
90%
MACD
ODDS (%)
Bearish Trend 4 days ago
80%
N/A
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
89%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
85%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
83%
Bullish Trend 10 days ago
67%
Declines
ODDS (%)
Bearish Trend 10 days ago
89%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
INTS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AVAL2.890.08
+2.85%
Grupo Aval Acciones Y Valores SA
CNET1.500.04
+2.51%
ZW Data Action Technologies Inc
SAGE9.200.12
+1.32%
Sage Therapeutics
CAAS4.180.05
+1.21%
China Automotive Systems
CF94.650.80
+0.85%
CF Industries Holding

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with KYMR. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
-2.63%
KYMR - CCCC
56%
Loosely correlated
+0.58%
CRBU - CCCC
54%
Loosely correlated
N/A
FATE - CCCC
53%
Loosely correlated
N/A
BEAM - CCCC
53%
Loosely correlated
+0.65%
RXRX - CCCC
51%
Loosely correlated
+1.15%
More